This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
Specialty drug company New River Pharmaceuticals netted $30mm through its initial public offering of 4.2mm shares sold at $8 apiece. When the company originally filed in May, it hoped to sell the stock for between $10-14 a share.
Already a Biomedtracker subscriber?You have access to the full deal record through your subscription
Want to become a subscriber?Subscribers get more deal details, updates, deal financials and deal products.Questions?